DUBLIN--(BUSINESS WIRE)--The "Medical Cannabis Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Product Type" report has been added to ResearchAndMarkets.com's offering. This report describes the global market size of Medical Cannabis from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For the geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc. For the competitor segment, the report includes global key players of Medical Cannabis as well as some small players. The information for each competitor includes: Company Profile Main Business Information SWOT Analysis Sales Volume, Revenue, Price and Gross Margin Market Share Types Segment: Dronabinol Nabilone Cannabidiol Cannabinol Scope Base Year: 2022 Historical Data: from 2017 to 2021 Forecast Data: from 2022 to 2027 Key Topics Covered: Chapter 1 Executive Summary Chapter 2 Abbreviation and Acronyms Chapter 3 Preface 3.1 Research Scope 3.2 Research Sources 3.2.1 Data Sources 3.2.2 Assumptions 3.3 Research Method Chapter 4 Market Landscape 4.1 Market Overview 4.2 Classification/Types 4.3 Application/End Users Chapter 5 Market Trend Analysis 5.1 Introduction 5.2 Drivers 5.3 Restraints 5.4 Opportunities 5.5 Threats 5.6 Covid-19 Impact Chapter 6 Industry Chain Analysis 6.1 Upstream/Suppliers Analysis 6.2 Medical Cannabis Analysis 6.2.1 Technology Analysis 6.2.2 Cost Analysis 6.2.3 Market Channel Analysis 6.3 Downstream Buyers/End Users Chapter 7 Latest Market Dynamics 7.1 Latest News 7.2 Merger and Acquisition 7.3 Planned/Future Project 7.4 Policy Dynamics Chapter 8 Trading Analysis 8.1 Export of Medical Cannabis by Region 8.2 Import of Medical Cannabis by Region 8.3 Balance of Trade Chapter 9 Historical and Forecast Medical Cannabis Market in North America (2017-2027) 9.1 Medical Cannabis Market Size 9.2 Medical Cannabis Demand by End Use 9.3 Competition by Players/Suppliers 9.4 Type Segmentation and Price 9.5 Key Countries Analysis 9.5.1 United States 9.5.2 Canada 9.5.3 Mexico Chapter 10 Historical and Forecast Medical Cannabis Market in South America (2017-2027) 10.1 Medical Cannabis Market Size 10.2 Medical Cannabis Demand by End Use 10.3 Competition by Players/Suppliers 10.4 Type Segmentation and Price 10.5 Key Countries Analysis 10.5.1 Brazil 10.5.2 Argentina 10.5.3 Chile 10.5.4 Peru Chapter 11 Historical and Forecast Medical Cannabis Market in Asia & Pacific (2017-2027) 11.1 Medical Cannabis Market Size 11.2 Medical Cannabis Demand by End Use 11.3 Competition by Players/Suppliers 11.4 Type Segmentation and Price 11.5 Key Countries Analysis 11.5.1 China 11.5.2 India 11.5.3 Japan 11.5.4 South Korea 11.5.5 Southeast Asia 11.5.6 Australia Chapter 12 Historical and Forecast Medical Cannabis Market in Europe (2017-2027) 12.1 Medical Cannabis Market Size 12.2 Medical Cannabis Demand by End Use 12.3 Competition by Players/Suppliers 12.4 Type Segmentation and Price 12.5 Key Countries Analysis 12.5.1 Germany 12.5.2 France 12.5.3 United Kingdom 12.5.4 Italy 12.5.5 Spain 12.5.6 Belgium 12.5.7 Netherlands 12.5.8 Austria 12.5.9 Poland 12.5.10 Russia Chapter 13 Historical and Forecast Medical Cannabis Market in MEA (2017-2027) 13.1 Medical Cannabis Market Size 13.2 Medical Cannabis Demand by End Use 13.3 Competition by Players/Suppliers 13.4 Type Segmentation and Price 13.5 Key Countries Analysis 13.5.1 Egypt 13.5.2 Israel 13.5.3 South Africa 13.5.4 Gulf Cooperation Council Countries 13.5.5 Turkey Chapter 14 Summary For Global Medical Cannabis Market (2017-2022) 14.1 Medical Cannabis Market Size 14.2 Medical Cannabis Demand by End Use 14.3 Competition by Players/Suppliers 14.4 Type Segmentation and Price Chapter 15 Global Medical Cannabis Market Forecast (2022-2027) 15.1 Medical Cannabis Market Size Forecast 15.2 Medical Cannabis Demand Forecast 15.3 Competition by Players/Suppliers 15.4 Type Segmentation and Price Forecast Chapter 16 Analysis of Global Key Vendors GW Pharmaceuticals plc Medigrow Akanda Corp. Spectrum Cannabis Bedrocan Verve Dynamic TerraTech Corp. Cannabis Science Inc. Peak Pharmaceuticals Inc. Cannabis-Rx Inc Nemus Biosciences Inc. Gb Sciences Insys Therapeutics Alkem Laboratories Akorn Ascent Pharmaceuticals TEVA Greenwich Biosciences Cronos Group Aurora Cannabis Aphria Tilray Constellation Brands MedBox Inc. TerraTech Corp. Cannabis Science Inc. Phoenix Life Sciences International Limited. MGC Pharma For more information about this report visit https://www.researchandmarkets.com/r/hxys1t
http://dlvr.it/Sc033j
No comments:
Post a Comment